641 results
Search Results
2. Evaluating the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe programme, what's worked and what more needs to be done?
3. Unmet needs for HIV ancillary care services by healthcare coverage and Ryan White HIV/AIDS program assistance.
4. The application of new metrics for understanding trends in undiagnosed HIV among key populations.
5. Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countries.
6. Physical activity is associated with adiposity in older adults with HIV in the modern HIV era.
7. Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections.
8. Evaluation of the diagnostic efficacy of EC-Test for latent tuberculosis infection in ambulatory people with HIV.
9. Evaluating the association of antiretroviral therapy and immune status with hypertensive disorders of pregnancy among people with HIV.
10. HIV pre-exposure prophylaxis initiation, persistence, and adherence during pregnancy through the postpartum period.
11. COVID-19 in people with HIV in the Netherlands.
12. Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort.
13. Pharmacogenomic panel testing provides insight and enhances medication management in people with HIV.
14. Consequences of a changing US strategy in the global HIV investment landscape.
15. Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum.
16. Optimizing and validating a pediatric screening tool to more efficiently test and identify children living with HIV.
17. Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV.
18. Invisible, but not absent.
19. Intersectionality-informed analysis of durable viral suppression disparities in people with HIV.
20. Prevalence of neurodevelopmental delays in infants with perinatal HIV infection in comparison with HIV exposure in rural South Africa.
21. Cost of improved test and treat strategies in Indonesia.
22. Postural instability in HIV infection: relation to central and peripheral nervous system markers.
23. Hypertensive disorders of pregnancy and HIV: analysis of a province-wide cohort during 2018 and 2019.
24. Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the United States.
25. The impact of attrition on the transmission of HIV and drug resistance.
26. The risks associated with stopping injectable antiretroviral treatment in women who are trying to conceive: a case series.
27. The role of social support on cognitive function among midlife and older adult MSM.
28. Factors associated with reduced function and quality of life among adult people with HIV with depression and substance use in the Asia-Pacific region.
29. Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis- and HIV-endemic region.
30. Impacts of intimate partner violence and sexual abuse on antiretroviral adherence among adolescents living with HIV in South Africa.
31. Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic.
32. Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV.
33. Seroconversion and persistence of neutralizing antibody response after yellow fever vaccination in patients with perinatally acquired HIV infection.
34. HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States.
35. Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action.
36. The importance of exercise and physical activity in older adults with HIV.
37. Is there a link between antiretroviral therapy and hypertensive disorders of pregnancy?
38. Higher epicardial fat in older adults living with HIV with viral suppression and relationship with liver steatosis, coronary calcium and cardiometabolic risks: Erratum.
39. Provision of HIV preexposure prophylaxis to female patients seeking family planning services in the United States.
40. A prospective study on adverse childhood experiences and HIV-related risk among adolescents in Malawi.
41. Multiomic analysis reveals microbiome-related relationships between cocaine use and metabolites.
42. Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi.
43. The impact, effectiveness and outcomes of targeted screening thresholds for programmatic latent tuberculosis infection testing in HIV.
44. Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus.
45. Routine programmatic data show a positive population-level impact of HIV self-testing: the case of Côte d'Ivoire and implications for implementation.
46. Mechanisms linking gender-based violence to worse HIV treatment and care outcomes among women in the United States.
47. Longitudinal HIV care outcomes by gender identity in the United States.
48. Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era.
49. Moving from the prediction of fractures to the prediction of falls in an aging HIV scenario.
50. Assessing concordance of HIV risk behaviors collected by different surveillance systems.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.